Early androgen suppression may reduce disease progression and improve long term survival compared with deferred androgen suppression in locally advanced prostate cancer
- PMID: 12787718
- DOI: 10.1016/s0305-7372(03)00119-1
Early androgen suppression may reduce disease progression and improve long term survival compared with deferred androgen suppression in locally advanced prostate cancer
Comment on
-
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.Cochrane Database Syst Rev. 2002;(1):CD003506. doi: 10.1002/14651858.CD003506. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2019 Jun 11;6:CD003506. doi: 10.1002/14651858.CD003506.pub2. PMID: 11869665 Updated.
Similar articles
-
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.Lancet Oncol. 2014 Sep;15(10):1076-89. doi: 10.1016/S1470-2045(14)70328-6. Epub 2014 Aug 14. Lancet Oncol. 2014. PMID: 25130995 Clinical Trial.
-
Duration of androgen suppression in the treatment of prostate cancer.N Engl J Med. 2009 Jun 11;360(24):2516-27. doi: 10.1056/NEJMoa0810095. N Engl J Med. 2009. PMID: 19516032 Clinical Trial.
-
Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.Eur Urol. 2014 Nov;66(5):829-38. doi: 10.1016/j.eururo.2013.07.024. Epub 2013 Jul 24. Eur Urol. 2014. PMID: 23932338 Clinical Trial.
-
Locally advanced prostate cancer: effective treatments, but many adverse effects.Prescrire Int. 2013 Jan;22(134):18-20, 22-3. Prescrire Int. 2013. PMID: 23367679 Review.
-
[Radiation therapy of locally advanced prostate cancer].Urologe A. 2017 Nov;56(11):1402-1409. doi: 10.1007/s00120-017-0511-4. Urologe A. 2017. PMID: 28983664 Review. German.
Cited by
-
Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.Cochrane Database Syst Rev. 2019 Jun 11;6(6):CD003506. doi: 10.1002/14651858.CD003506.pub2. Cochrane Database Syst Rev. 2019. PMID: 31194882 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources